Literature DB >> 16456545

Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint.

Gustavo Pedraza-Alva1, Miroslav Koulnis, Colette Charland, Tina Thornton, James L Clements, Mark S Schlissel, Mercedes Rincón.   

Abstract

Delay of cell cycle progression in response to double-strand DNA breaks (DSBs) is critical to allow time for DNA repair and prevent cellular transformation. Here, we show that the p38 mitogen-activated protein (MAP) kinase signaling pathway is activated in immature thymocytes along with TcRbeta gene V(D)J recombination. Active p38 MAP kinase promotes a G2/M cell cycle checkpoint through the phosphorylation and activation of p53 in these cells in vivo. Inactivation of p38 MAP kinase and p53 is required for DN3 thymocytes to exit the G2/M checkpoint, progress through mitosis and further differentiate. We propose that p38 MAP kinase is activated by V(D)J-mediated DSBs and induces a p53-mediated G2/M checkpoint to allow DNA repair and prevent cellular transformation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456545      PMCID: PMC1383553          DOI: 10.1038/sj.emboj.7600972

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.

Authors:  Terri L Messier; J Patrick O'Neill; Sai-Mei Hou; Janice A Nicklas; Barry A Finette
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

2.  Restoration of T cell development in RAG-2-deficient mice by functional TCR transgenes.

Authors:  Y Shinkai; S Koyasu; K Nakayama; K M Murphy; D Y Loh; E L Reinherz; F W Alt
Journal:  Science       Date:  1993-02-05       Impact factor: 47.728

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  Double-strand signal sequence breaks in V(D)J recombination are blunt, 5'-phosphorylated, RAG-dependent, and cell cycle regulated.

Authors:  M Schlissel; A Constantinescu; T Morrow; M Baxter; A Peng
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

Review 5.  Principles of CDK regulation.

Authors:  D O Morgan
Journal:  Nature       Date:  1995-03-09       Impact factor: 49.962

6.  Rapid histone H3 phosphorylation in response to growth factors, phorbol esters, okadaic acid, and protein synthesis inhibitors.

Authors:  L C Mahadevan; A C Willis; M J Barratt
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

7.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

8.  RAG-1-deficient mice have no mature B and T lymphocytes.

Authors:  P Mombaerts; J Iacomini; R S Johnson; K Herrup; S Tonegawa; V E Papaioannou
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

9.  Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27.

Authors:  N W Freshney; L Rawlinson; F Guesdon; E Jones; S Cowley; J Hsuan; J Saklatvala
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

10.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells.

Authors:  J Han; J D Lee; L Bibbs; R J Ulevitch
Journal:  Science       Date:  1994-08-05       Impact factor: 47.728

View more
  31 in total

1.  Negative regulation of human U6 snRNA promoter by p38 kinase through Oct-1.

Authors:  Bor-Ruei Lin; Ven Natarajan
Journal:  Gene       Date:  2012-01-28       Impact factor: 3.688

2.  TAO kinases mediate activation of p38 in response to DNA damage.

Authors:  Malavika Raman; Svetlana Earnest; Kai Zhang; Yingming Zhao; Melanie H Cobb
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

3.  The selenium analog of the chemopreventive compound S,S'-(1,4-phenylenebis[1,2-ethanediyl])bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer.

Authors:  Arunangshu Das; James Bortner; Dhimant Desai; Shantu Amin; Karam El-Bayoumy
Journal:  Chem Biol Interact       Date:  2009-03-20       Impact factor: 5.192

Review 4.  The sticky business of histone H2AX in V(D)J recombination, maintenance of genomic stability, and suppression of lymphoma.

Authors:  Bu Yin; Craig H Bassing
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 5.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

6.  Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.

Authors:  Tina M Thornton; Gustavo Pedraza-Alva; Bin Deng; C David Wood; Alexander Aronshtam; James L Clements; Guadalupe Sabio; Roger J Davis; Dwight E Matthews; Bradley Doble; Mercedes Rincon
Journal:  Science       Date:  2008-05-02       Impact factor: 47.728

7.  Requirement for dicer in survival of proliferating thymocytes experiencing DNA double-strand breaks.

Authors:  Brenna L Brady; Levi J Rupp; Craig H Bassing
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

Review 8.  Lymphocyte development: integration of DNA damage response signaling.

Authors:  Jeffrey J Bednarski; Barry P Sleckman
Journal:  Adv Immunol       Date:  2012       Impact factor: 3.543

9.  Nuclear localization of p38 MAPK in response to DNA damage.

Authors:  C David Wood; Tina M Thornton; Guadalupe Sabio; Roger A Davis; Mercedes Rincon
Journal:  Int J Biol Sci       Date:  2009-06-16       Impact factor: 6.580

10.  Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination.

Authors:  Bu Yin; Velibor Savic; Marisa M Juntilla; Andrea L Bredemeyer; Katherine S Yang-Iott; Beth A Helmink; Gary A Koretzky; Barry P Sleckman; Craig H Bassing
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.